Vantage Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$16K Hold
125
﹤0.01% 463
2018
Q2
$13K Hold
125
﹤0.01% 495
2018
Q1
$13K Hold
125
﹤0.01% 519
2017
Q4
$15K Hold
125
﹤0.01% 505
2017
Q3
$14K Hold
125
﹤0.01% 505
2017
Q2
$16K Hold
125
﹤0.01% 468
2017
Q1
$15K Hold
125
﹤0.01% 458
2016
Q4
$12K Hold
125
﹤0.01% 483
2016
Q3
$16K Hold
125
0.01% 425
2016
Q2
$15K Hold
125
0.01% 463
2016
Q1
$13K Hold
125
0.01% 485
2015
Q4
$12K Hold
125
0.01% 476
2015
Q3
$11K Sell
125
-197
-61% -$19.7K 0.01% 484
2015
Q2
$34K Sell
322
-323
-50% -$35.7K 0.02% 289
2015
Q1
$74K Buy
645
+541
+520% +$61.7K 0.02% 280
2014
Q4
$11K Hold
104
0.01% 492
2014
Q3
$10K Hold
104
0.01% 474
2014
Q2
$10K Hold
104
0.01% 476
2014
Q1
$10K Hold
104
0.01% 433
2013
Q4
$9K Buy
+104
New +$9K 0.01% 413

Other funds holding ZBH

Vantage Investment Advisors's ZBH Position: Q3 2018 in Review

Vantage Investment Advisors held its Zimmer Biomet (ZBH) position steady in Q3 2018 at 125 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Vantage Investment Advisors first reported a position in ZBH in Q4 2013 and has held it in 20 quarters since. The position peaked at $74K in Q1 2015. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Vantage Investment Advisors held 125 shares of Zimmer Biomet worth $16K as of Q3 2018.
  • Vantage Investment Advisors left its Zimmer Biomet share count unchanged in Q3 2018.
  • Zimmer Biomet made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #463 holding.
  • Vantage Investment Advisors first reported a position in Zimmer Biomet in Q4 2013 and has held it in 20 quarters since.
  • Vantage Investment Advisors's Zimmer Biomet position peaked at $74K in Q1 2015.
  • 891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.